Monthly revenue and year-on-year change for OBI Pharma (4174) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | OBI Pharma | YoY | PEC | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.3 million | -58.7% | NT$2.84 billion | +102.0% |
| Sep 2026 | NT$1.6 million | -69.7% | NT$2.64 billion | +100.0% |
| Aug 2026 | NT$817,000 | -23.4% | NT$2.62 billion | +105.4% |
| Jul 2026 | NT$4.1 million | -0.6% | NT$2.51 billion | +92.6% |
| Jun 2026 | NT$10.3 million | +165.9% | NT$2.33 billion | +94.9% |
| May 2026 | NT$1.5 million | -59.5% | NT$2.46 billion | +108.5% |
| Apr 2026 | NT$3.4 million | -32.8% | NT$2.06 billion | +68.3% |
| Mar 2026 | NT$2.6 million | -9.8% | NT$1.94 billion | +64.4% |
| Feb 2026 | NT$1.6 million | -85.5% | NT$1.6 billion | +56.7% |
| Jan 2026 | NT$1.3 million | +140.2% | NT$1.58 billion | +49.8% |
| Dec 2025 | NT$7.4 million | -5.9% | NT$1.92 billion | +69.9% |
| Nov 2025 | NT$7.9 million | +306.2% | NT$1.55 billion | +53.0% |
| Oct 2025 | NT$5.5 million | +215.0% | NT$1.4 billion | +53.6% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16